Posted by Michael Wonder on 28 Jan 2026
New hope for people with breathing condition, COPD, as NICE approves innovative treatment
26 January 2026 - Almost 30,000 people in England with a respiratory disease called COPD (chronic obstructive pulmonary disease) could have their lives transformed after NICE today recommended a new targeted treatment that can be taken at home.
Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings the disease under better control, helping to reduce flare-ups, improve breathing and offers new hope to patients with limited treatment options.
